Coenzyme Q10 Ameliorates Pancreatic Fibrosis via the ROS-Triggered mTOR Signaling Pathway

Figure 8

(a) Quantification of western blots for LC3 expression levels in the various groups compared to the normal control group (; ). (b) Quantification of western blots for Atg5 expression levels in the various groups compared to the normal control group (; ). (c) Quantification of western blots for p-PI3K expression levels in the various groups compared to the normal control group (; ). (d) Quantification of western blots for p-AKT expression levels in the various groups compared to the normal control group (; ). (e) Quantification of western blots for p-mTOR expression levels in the various groups compared to the normal control group (; ). (f) Western blotting analysis for LC3, Atg5, p-PI3K, p-AKT, and p-mTOR expression levels of activated PSCs was performed after 72 h with CoQ10 treatment, as well as the addition of Rosup.

(a)

(b)

(c)

(d)

(e)

(f)